Literature DB >> 28017853

Pre-treatment with nimodipine and 7.5% hypertonic saline protects aged rats against postoperative cognitive dysfunction via inhibiting hippocampal neuronal apoptosis.

Zhang Qi1, Yuan Tianbao1, Li Yanan1, Xin Xi1, He Jinhua1, Wang Qiujun2.   

Abstract

OBJECTIVE: This study aimed to investigate the effects of pre-treatment with nimodipine and 7.5% hypertonic saline (HS) on postoperative cognitive dysfunction (POCD) in aged rats.
METHODS: Healthy Sprague-Dawley aged rats were randomly assigned into 4 groups: POCD group, nimodipine group, HS group, and nimodipine+HS group. Rats in POCD group received normal saline injection and then splenectomy 30min later under 1.8% isoflurane inhalation for 2h. In remaining groups, rats received injection of 1mg/kg nimodipine (i.p) and/or 4ml/kg 7.5% HS (i.v) and then splenectomy. Morris water maze test was performed before and after surgery. The hippocampus was harvested for the detection of neuronal apoptosis rate (AR), cytoplasmic calcium ([Ca2+]i), Bcl-2 and Bax mRNA expression and hippocampal neuronal ultrastructure.
RESULTS: When compared with POCD group, the latency to escape, neuronal AR, [Ca2+]i, Bax mRNA expression and Bax/Bcl-2 ratio reduced dramatically, but the times of crossing the platform and Bcl-2 mRNA expression increased significantly (P<0.05) in nimodipine group, NS group and nimodipine+HS group. In addition, the latency to escape, neuronal AR, [Ca2+]i, Bax mRNA expression and Bax/Bcl-2 ratio reduced markedly, but the times of crossing the platform and Bcl-2 mRNA expression increased significantly in nimodipine+HS group as compared to nimodipine group and NS group (P<0.05). Hippocampal neuronal ultrastructure damage was observed in all 4 groups, but it was the mildest in nimodipine+HS group.
CONCLUSION: Pre-treatment with both nimodipine and 7.5% HS exerts better protective effects, which is related to the inhibition of hippocampal neuronal apoptosis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytoplasmic calcium; Hippocampus; Neuronal apoptosis; Post-operative cognition dysfunction

Mesh:

Substances:

Year:  2016        PMID: 28017853     DOI: 10.1016/j.bbr.2016.12.029

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  Surgery-induced downregulation of hippocampal sirtuin-1 contributes to cognitive dysfunction by inhibiting autophagy and activating apoptosis in aged mice.

Authors:  Qian-Juan Fang; Bing-Huan Chi; Qi-Cheng Lin; Chen-Miao Huang; Shao-Wu Jin; Jia-Jing Cai; Ke Nan; Yuan Han; Yuan-Xiang Tao; Hong Cao; Jun Li
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

2.  Hypertonic saline for prevention of delirium in geriatric patients who underwent hip surgery.

Authors:  Xi Xin; Fei Xin; Xuguang Chen; Qi Zhang; Yanan Li; Shuping Huo; Chongfu Chang; Qiujun Wang
Journal:  J Neuroinflammation       Date:  2017-11-14       Impact factor: 8.322

3.  Differentially expressed lncRNAs and miRNAs with associated ceRNA networks in aged mice with postoperative cognitive dysfunction.

Authors:  Changwei Wei; Ting Luo; Shanshan Zou; Xiaobin Zhou; Wenzhen Shen; Xiaolin Ji; Qi Li; Anshi Wu
Journal:  Oncotarget       Date:  2017-06-03

4.  Nrdp1 is involved in hippocampus apoptosis in cardiopulmonary bypass-induced cognitive dysfunction via the regulation of ErbB3 protein levels.

Authors:  Jie Zheng; Su Min; Bin Hu; Qin Liu; Yunqiang Wan
Journal:  Int J Mol Med       Date:  2019-01-28       Impact factor: 4.101

5.  Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia.

Authors:  Kai-Xin Yao; Hang Lyu; Mei-Hua Liao; Lin Yang; Yin-Ping Gao; Qi-Bing Liu; Cheng-Kun Wang; Ying-Mei Lu; Guo-Jun Jiang; Feng Han; Ping Wang
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

Review 6.  Anesthesiology and cognitive impairment: a narrative review of current clinical literature.

Authors:  Jillian C Belrose; Ruediger R Noppens
Journal:  BMC Anesthesiol       Date:  2019-12-27       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.